Physicians' efficacy requirements for prescribing medications to persons with Alzheimer's disease

Canadian Journal on Aging

Volumn 26, Issue 2, 2007, Pages 139-148

  Oremus, Mark ^a,b,c   Wolfson, Christina ^a,b   Bergman, Howard ^a   Vandal, Alain C ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Aging; Alzheimer's disease; Drug treatment; Efficacy; Physician; Prescribing

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION;

ADULT; AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRESCRIPTIONS, DRUG; QUEBEC; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 34548309083     PISSN: 07149808     EISSN: None     Source Type: Journal    
DOI: 10.3138/cja.26.2.139     Document Type: Article

References (21)

1. Mohs RC, Rosen WG, Davis KL. The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19:448-450.
2. Knopman DS, Knapp MJ, Gracon SI, Davis CS. The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. Neurology 1994;44:2315-2321.
3. Rockwood K. Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:677-685.
4. Rockwood K, Graham JE, Fay S, for the ACADIE Investigators. Goal setting and attainment in Alzheimer's disease patients treated with donepezil. J Neurol Neurosurg Psychiatry 2002;73:500-507.
5. Rockwood K, Joffres C, for the Halifax Consensus Conference on Understanding the Effects of Dementia Treatment. Improving clinical descriptions to understand the effects of dementia treatment: consensus recommendations. Int J Geriatr Psychiatry 2002;17:1006-1011.
6. Karlawish JHT, Casarett DJ, James BD, Tenhave T, Clark CM, Asch DA. Why would caregivers not want to treat their relative's Alzheimer's disease? J Am Geriatr Soc 2003;51:1391-1397.
7. AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004;363:2105-2115.
8. Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, et al. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: A rapid and systematic review. Health Technol Assess 2001;5:1-137.
9. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, et al. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003;348:1333-1341.
10. Bergman H, Hogan DB, Patterson C, Chertkow H, Clarfield AM. Dementia. In: Jones R, Britten N, Culpepper L, Gass D, Grol R, Mant D, et al., editors. Oxford textbook of primary medical care. Oxford: Oxford University Press; 2003. p. 1251-1254.
11. Dillman DA. Mail and Internet surveys: The tailored design method. 2nd ed. New York: Wiley; 2000.
12. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002;324:1183-1191.
13. Morris CJ, Cantrill JA, Weiss MC. GP survey response rate: a miscellany of influencing factors. Fam Pract 2001;18:454-456.
14. Cummings SR, Strull W, Nevitt MC, Hulley SB. Planning the measurements: questionnaires. In: Hulley SB, Cummings SR, Browner WS, Newman TB, Hearst N, editors. Designing clinical research. Baltimore: Williams and Wilkins; 1988. p. 42-52.
15. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000.
16. Peat JK, Mellis C, Williams K, Xuan W. Health science research: A handbook of quantitative methods. London: Sage; 2002.
17. Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
18. Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: a data analyst's perspective. Multivariate Behav Res 1998;33:545-571.
19. Schimert J, Schafer JL, Hesterberg T, Fraley C, Clarkson DB. Analyzing data with missing values in S-plus. Seattle, WA: Insightful Corporation; 2001.
20. Kramer MS. Clinical epidemiology and biostatistics: a primer for clinical investigators and decision-makers. Berlin: Springer-Verlag; 1988.
21. Kaner EFS, Haighton CA, McAvoy BR. "So much post, so busy with practice - so, no time!" A telephone survey of general practitioners' reasons for not participating in postal questionnaire surveys. Br J Gen Pract 1998;48:1067-1069.